Scientists have discovered that cancer cells behave differently in the microgravity of space, growing three times faster than on Earth. This rapid growth allows for quicker experimentation with treatments. Focusing on the gene ADAR1, which is linked to cancer’s ability to evade the immune system and resist therapy, researchers have found that inhibiting this gene can prevent cancer cells from replicating. A drug called reexanib has been successful in shutting down ADAR1 in trials conducted on the International Space Station, offering hope for a potential ‘cancer kill switch.’ However, the drug is not yet ready for clinical trials on Earth.
- Cancer cells sent to the International Space Station grew three times in size within 10 days, a process that would take years on Earth.
- The absence of Earth-like gravity, or microgravity, in space is believed to be the main factor affecting the cancer cells’ rapid growth.
- Researchers are studying a specific gene, ADAR1, which helps cancer clone itself and evade the immune system.
- By targeting ADAR1 with a drug called reexanib, scientists were able to prevent the replication of cancer cells in space.
- The astronauts on the mission contributed to the research by donating their blood to study the effect of space on stem cells.
- While promising, the drug reexanib is still in the experimental stages and not yet available for human trials on Earth.
- Clinical trials for the drug are targeted to begin before the end of the year, with the aim of finding a treatment for patients who need it urgently.
The British Broadcasting Corporation is a British public service broadcaster headquartered at Broadcasting House in London. Originally established in 1922 as the British Broadcasting Company, it evolved into its current state with its current name on New Year’s Day 1927.
AllSides Media Bias Rating: Center
https://www.allsides.com/news-source/bbc-news-media-bias
Official website: https://www.bbc.com/
Original video here.
This summary has been generated by AI.